Metagenomi Therapeutics, Inc. (MGX) total debt

Total debt · fiscal 2025
$40.66M

Metagenomi Therapeutics, Inc. (MGX) carried total debt of $40.66M at the end of fiscal 2025 (December 31, 2025). That is 11.2% lower than the $45.78M of fiscal 2024. Figures as of 18 Nov 2026, 09:25 UTC, from Yahoo Finance.

Key facts

Total debt, fiscal 2025
$40.66M
Change on fiscal 2024
−11.2%
Highest on record
$48.23Mfiscal 2023
Lowest on record
$18.57Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Metagenomi Therapeutics, Inc. total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $48.23M in fiscal 2023 and the lowest $18.57M in fiscal 2022.

Total debt was 0.3× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Metagenomi Therapeutics, Inc. total debt, year by year

Metagenomi Therapeutics, Inc. (MGX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$40.66M 11.2% down0.3×
2024$45.78M 5.1% down0.2×
2023$48.23M 159.7% up—
2022$18.57M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on MGX

Metagenomi Therapeutics, Inc., figure by figure

Metagenomi Therapeutics, Inc. (MGX) overview: price, valuation and scorecard

Metagenomi Therapeutics, Inc. total debt: questions and answers

How much debt does Metagenomi Therapeutics, Inc. have?

Metagenomi Therapeutics, Inc. (MGX) carried total debt of $40.66M at the end of fiscal 2025 (December 31, 2025). That is 11.2% lower than the $45.78M of fiscal 2024.

What are the highest and lowest total debt figures on record for Metagenomi Therapeutics, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was $48.23M in fiscal 2023 and the lowest $18.57M in fiscal 2022.

How does Metagenomi Therapeutics, Inc.'s debt compare with its equity?

Total debt was 0.3× shareholders' equity at the end of fiscal 2025.

How is Metagenomi Therapeutics, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Metagenomi Therapeutics, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Metagenomi Therapeutics, Inc. (MGX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/MGX/total-debt

Underlying data: Yahoo Finance.